secretome

Phase 2Cell therapy

BBaermed

secretome is one of 105 biologic programs targeting Androgenetic Alopecia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

104

Competitors

Pipeline

Status by Indication[3][1]

Indication

Androgenetic AlopeciaRecruiting

EpilepsyNot yet recruiting

Acne VulgarisNot yet recruiting

CirrhosisNot yet recruiting

Androgenetic AlopeciaPhase 2

Recruiting

EpilepsyPhase 1

Not yet recruiting

Acne VulgarisPhase 2

Not yet recruiting

CirrhosisPhase 1

Not yet recruiting

Competition

Competitive Landscape

87 competitors in Epilepsy

#DrugCompanyPhaseTrials

Vimpat

UCB

Approved

11 2

Tegretol

Novartis

Approved

11 3

Trileptal

Novartis

Approved

7 4

Fycompa

CCatalyst Biosciences

Approved

14 5

Briviact

UCB

Phase 3

15 6

Dilantin

VViatris Specialty LLC

Approved

3 7

Epidiolex

Jazz Pharmaceuticals

Phase 3

9 8

Ketalar

AAultman Health Foundation

Approved

1 9

Lanoxin

Coumadin

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Stem Cell1 trial

Skin Rejuvenation Using Stem Cell Secretome

Completed·CCOR clinic of Regenerative Medicine·Phase 1·NCT06217627·49 enrolled

Acne Vulgaris1 trial

The Relationship Between Microbioma Balance and Acne Vulgaris as a New Acne Treatment

Not yet recruiting·UUniversitas Padjadjaran·Phase 2·NCT06925386·64 enrolled

Mesenchymal Stem Cell1 trial

The Effects of Mesenchymal Stem Cell Secretome in Lupus Patients

Completed·UUniversitas Sebelas Maret·Phase 1/2·NCT05921058·15 enrolled

Androgenetic Alopecia1 trial

Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

Recruiting·PPT. Prodia Stem Cell Indonesia·Phase 1/2·NCT07429253·40 enrolled

Cirrhosis1 trial

Safety and Feasibility of Human Umbilical Cord Mesenchymal Stem Cell-Derived Secretome in the Treatment of Liver Cirrhosis: a Comprehensive Evaluation of Fibrosis Reduction, Immunomodulation, and Hepatic Regeneration: a Single Center, Randomized, Phase I Clinical Trial

Not yet recruiting·BBaermed·Phase 1·NCT06629909·54 enrolled

5 more indications

Cognitive impairment1 trial

Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Moderate Neurocognitive Impairment (Dementia)

Not yet recruiting·BBaermed·Phase 1·NCT06632470·54 enrolled

TIA1 trial

Potential Injection of Human Umbilical Cord Secretome in the Case of Trophic Ulcers (Pre-post Intervention)

Completed·YYohanes Firmansyah, dr, MH, MM·Phase 1·NCT05777213·27 enrolled

Epilepsy1 trial

Clinical Utility and Safety of Human Umbilical Cord Mesenchymal Stem Cell Secretome in Drug Resistant Epilepsy Single Center, Non-randomized, Phase I Clinical Trial

Not yet recruiting·BBaermed·Phase 1·NCT06638970·54 enrolled

Carpal Tunnel Syndrome (CTS)1 trial

Effectiveness of Amniotic Membrane Combined With Secretome as an Adjunct to Carpal Tunnel Release Surgery: Evaluation Using the Boston Carpal Tunnel Questionnaire and Electromyography

Recruiting·PPT. Prodia Stem Cell Indonesia·Phase 1·NCT07723313·30 enrolled

ACL Injury1 trial

Comparison of Six-Month Functional Outcomes Following Anterior Cruciate Ligament (ACL) Reconstruction Using Peroneus Longus Tendon Grafts With Adjunctive Secretome Injection Versus Without Secretome Injection

Completed·PPT. Prodia Stem Cell Indonesia·Preclinical·NCT07723625·24 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for secretome. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — secretome compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for secretome. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Baermed company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Cell therapy[2]
Highest Phase: Phase 2[1]
Company: BBaermed

secretome

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Stem Cell1 trial

Acne Vulgaris1 trial

Mesenchymal Stem Cell1 trial

Androgenetic Alopecia1 trial

Cirrhosis1 trial

Cognitive impairment1 trial

TIA1 trial

Epilepsy1 trial

Carpal Tunnel Syndrome (CTS)1 trial

ACL Injury1 trial

References

Drug Info

Quick Facts

Related News